281 related articles for article (PubMed ID: 14552651)
21. [Individualized treatment with antidepressants].
Köhler S; Arndt A; Sterzer P; Bschor T
Fortschr Neurol Psychiatr; 2013 Feb; 81(2):104-16; quiz 117-8. PubMed ID: 23412962
[No Abstract] [Full Text] [Related]
22. Augmentation effect of combination therapy of aripiprazole and antidepressants on forced swimming test in mice.
Bourin M; Chenu F; Prica C; Hascoët M
Psychopharmacology (Berl); 2009 Sep; 206(1):97-107. PubMed ID: 19517098
[TBL] [Abstract][Full Text] [Related]
23. The noradrenergic action in antidepressant treatments: pharmacological and clinical aspects.
Dell'Osso B; Palazzo MC; Oldani L; Altamura AC
CNS Neurosci Ther; 2011 Dec; 17(6):723-32. PubMed ID: 21155988
[TBL] [Abstract][Full Text] [Related]
24. Future directions for serotonin and antidepressants.
Artigas F
ACS Chem Neurosci; 2013 Jan; 4(1):5-8. PubMed ID: 23336036
[TBL] [Abstract][Full Text] [Related]
25. Extrapyramidal symptoms associated with antidepressants--a review of the literature and an analysis of spontaneous reports.
Madhusoodanan S; Alexeenko L; Sanders R; Brenner R
Ann Clin Psychiatry; 2010 Aug; 22(3):148-56. PubMed ID: 20680187
[TBL] [Abstract][Full Text] [Related]
26. Is there a role for a pure noradrenergic drug in the treatment of depression?
Montgomery SA
Eur Neuropsychopharmacol; 1997 Apr; 7 Suppl 1():S3-9; discussion S71-3. PubMed ID: 9169305
[TBL] [Abstract][Full Text] [Related]
27. Triple reuptake inhibitors as potential next-generation antidepressants: a new hope?
Sharma H; Santra S; Dutta A
Future Med Chem; 2015; 7(17):2385-406. PubMed ID: 26619226
[TBL] [Abstract][Full Text] [Related]
28. Problems with currently available antidepressants.
Gumnick JF; Nemeroff CB
J Clin Psychiatry; 2000; 61 Suppl 10():5-15. PubMed ID: 10910012
[TBL] [Abstract][Full Text] [Related]
29. Predictive value of pharmacological activity for the relative efficacy of antidepressant drugs. Meta-regression analysis.
Freemantle N; Anderson IM; Young P
Br J Psychiatry; 2000 Oct; 177():292-302. PubMed ID: 11116769
[TBL] [Abstract][Full Text] [Related]
30. Monoamine neurocircuitry in depression and strategies for new treatments.
Hamon M; Blier P
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():54-63. PubMed ID: 23602950
[TBL] [Abstract][Full Text] [Related]
31. The symptoms, neurobiology, and current pharmacological treatment of depression.
To SE; Zepf RA; Woods AG
J Neurosci Nurs; 2005 Apr; 37(2):102-7. PubMed ID: 15902953
[TBL] [Abstract][Full Text] [Related]
32. Triple uptake inhibitors: therapeutic potential in depression and beyond.
Chen Z; Skolnick P
Expert Opin Investig Drugs; 2007 Sep; 16(9):1365-77. PubMed ID: 17714023
[TBL] [Abstract][Full Text] [Related]
33. New antidepressants in the treatment of neuropathic pain. A review.
Mattia C; Paoletti F; Coluzzi F; Boanelli A
Minerva Anestesiol; 2002 Mar; 68(3):105-14. PubMed ID: 11981519
[TBL] [Abstract][Full Text] [Related]
34. Duloxetine: a balanced and selective norepinephrine- and serotonin-reuptake inhibitor.
Westanmo AD; Gayken J; Haight R
Am J Health Syst Pharm; 2005 Dec; 62(23):2481-90. PubMed ID: 16303903
[TBL] [Abstract][Full Text] [Related]
35. [FDA approval for the antidepressive drug Cymbalta].
Krankenpfl J; 2004; 42(5-6):154. PubMed ID: 15527218
[No Abstract] [Full Text] [Related]
36. Evidence-based treatment paradigms for depressed patients with pain and physical symptoms.
Fishbain DA
J Clin Psychiatry; 2009 Jul; 70(7):e22. PubMed ID: 19653968
[TBL] [Abstract][Full Text] [Related]
37. New approaches to developing antidepressants by enhancing monoaminergic neurotransmission.
Bymaster FP; McNamara RK; Tran PV
Expert Opin Investig Drugs; 2003 Apr; 12(4):531-43. PubMed ID: 12665410
[TBL] [Abstract][Full Text] [Related]
38. Serotonergic and noradrenergic reuptake inhibitors: prediction of clinical effects from in vitro potencies.
Frazer A
J Clin Psychiatry; 2001; 62 Suppl 12():16-23. PubMed ID: 11430614
[TBL] [Abstract][Full Text] [Related]
39. Pharmacology of antidepressants.
Frazer A
J Clin Psychopharmacol; 1997 Apr; 17 Suppl 1():2S-18S. PubMed ID: 9090573
[TBL] [Abstract][Full Text] [Related]
40. Triple reuptake inhibitors for treating subtypes of major depressive disorder: the monoamine hypothesis revisited.
Prins J; Olivier B; Korte SM
Expert Opin Investig Drugs; 2011 Aug; 20(8):1107-30. PubMed ID: 21682663
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
